A detailed history of Ritholtz Wealth Management transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Ritholtz Wealth Management holds 51,261 shares of SRTS stock, worth $432,130. This represents 0.01% of its overall portfolio holdings.

Number of Shares
51,261
Previous 31,005 65.33%
Holding current value
$432,130
Previous $179,000 96.09%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

BUY
$5.95 - $8.95 $120,523 - $181,291
20,256 Added 65.33%
51,261 $351,000
Q3 2024

Oct 10, 2024

BUY
$4.93 - $7.05 $152,854 - $218,585
31,005 New
31,005 $179,000
Q3 2022

Oct 18, 2022

BUY
$7.64 - $14.97 $100,641 - $197,199
13,173 New
13,173 $165,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $140M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track Ritholtz Wealth Management Portfolio

Follow Ritholtz Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.